CJC-1295 w/o DAC 10mg + Ipamorelin 10mg Peptides
For researchers who value precision over promises, this disciplined dual-peptide pairing delivers clarity, consistency, and control.
Primavora CJC-1295 without DAC + Ipamorelin is a lyophilized peptide blend supplied in a sealed research vial. This non-flavored, research-only preparation combines two growth hormone secretagogue peptides with a total content of 20mg (10mg/10mg) to support reliable design and repeatability in controlled laboratory settings.
- 10mg CJC-1295 without DAC – A growth hormone–releasing hormone analog commonly evaluated for its short-acting, pulsatile signaling characteristics in preclinical studies.
- 10mg Ipamorelin – A selective ghrelin receptor agonist frequently studied for targeted growth hormone pathway activation and complementary use alongside GHRH analogs in research models.
As a non-edible, lyophilized powder, this blend is formulated for clean, controlled reconstitution per laboratory protocol. The material is designed to dissolve uniformly, supporting clear solutions, straightforward aliquoting, and consistent handling across experimental workflows. Each component is presented to enable deliberate study of individual and combined effects, offering researchers a dependable baseline for methodical investigation.
Primavora is built around rigorous standards—beginning with careful sourcing, followed by controlled handling and lot-level analytical testing for identity and purity. Vials are prepared for laboratory environments to protect integrity from fill to seal, helping maintain the quality parameters required for reproducible work. Documentation is maintained to support traceability and quality review.
Trust the details. This product reflects Primavora’s commitment to clarity, consistency, and responsible research supply—USA-based, quality-focused, and grounded in scientific discipline. For laboratory research only. Not for human consumption, injection, or therapeutic use.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin is a growth-hormone secretagogue that acts primarily through the ghrelin receptor pathway. It is often described as more selective than older secretagogues because it is studied for GH release with less interest in off-target hormone stimulation. For product copy, it should be described as a research peptide for endocrine signaling studies.
What is Ipamorelin typically studied for?
Ipamorelin is typically studied for endogenous growth-hormone release, GH/IGF-1-axis signaling, recovery-related models, and pulse-based endocrine research. It is commonly paired with GHRH analogs in blend products because those two signaling routes are often examined together.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Prima Vora are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
